Bujarski S - Search Results

1

Targeting B-cell maturation antigen for treatment and monitoring of relapsed/refractory multiple myeloma patients: a comprehensive review.

Yashar D, Regidor B, Goldwater MS, Bujarski S, Del Dosso A, Berenson JR. Yashar D, et al. Among authors: bujarski s. Ther Adv Hematol. 2024 Sep 14;15:20406207241275797. doi: 10.1177/20406207241275797. eCollection 2024. Ther Adv Hematol. 2024. PMID: 39290982 Free PMC article. Review.

2

Serum B-Cell Maturation Antigen Reflects Disease Status in a Patient Who Developed Nonsecretory Multiple Myeloma: A Case Report.

Danis R, Regidor B, Bujarski S, Jew S, Goldwater MS, Swift R, Eades BM, Emamy-Sadr M, Del Dosso A, Berenson J. Danis R, et al. Among authors: bujarski s. Case Rep Oncol. 2024 Jul 12;17(1):747-752. doi: 10.1159/000539814. eCollection 2024 Jan-Dec. Case Rep Oncol. 2024. PMID: 39015635 Free PMC article.

3

Medication development for AUD: A systematic review of clinical trial methodology.

Donato S, Meredith LR, Nieto SJ, Bujarski S, Ray LA. Donato S, et al. Among authors: bujarski s. Alcohol. 2024 Nov;120:194-203. doi: 10.1016/j.alcohol.2024.06.007. Epub 2024 Jul 5. Alcohol. 2024. PMID: 38972367

4

A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone.

Berenson JR, Limon A, Rice S, Safaie T, Boccia R, Yang H, Moezi M, Lim S, Schwartz G, Eshaghian S, Brobeck M, Swift R, Eades BM, Bujarski S, Sebhat Y, Ray R, Kim S, Del Dosso A, Vescio R. Berenson JR, et al. Among authors: bujarski s. Target Oncol. 2024 May;19(3):343-357. doi: 10.1007/s11523-024-01049-w. Epub 2024 Apr 20. Target Oncol. 2024. PMID: 38643346 Clinical Trial.

5

Response to Letter to the Editors regarding 'A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis'.

Grodin EN, Donato S, Du H, Green R, Bujarski S, Ray LA. Grodin EN, et al. Among authors: bujarski s. Alcohol Alcohol. 2023 Nov 11;58(6):690-691. doi: 10.1093/alcalc/agad066. Alcohol Alcohol. 2023. PMID: 37794750 Free PMC article.

6

Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients.

Jew S, Bujarski S, Regidor B, Emamy-Sadr M, Swift R, Eades B, Kim S, Eshaghian S, Berenson JR. Jew S, et al. Among authors: bujarski s. Target Oncol. 2023 Sep;18(5):735-747. doi: 10.1007/s11523-023-00990-6. Epub 2023 Sep 8. Target Oncol. 2023. PMID: 37682503

7

The incidence of translocation t(11;14) among patients with multiple myeloma in a single clinic.

Jew S, Goldwater MS, Bujarski S, Regidor B, Emamy-Sadr M, Swift R, Eades B, Said J, Berenson JR. Jew S, et al. Among authors: bujarski s. Am J Clin Pathol. 2024 Jan 4;161(1):16-23. doi: 10.1093/ajcp/aqad103. Am J Clin Pathol. 2024. PMID: 37611113

8

Efficacy of isatuximab in combination with steroids for the treatment of relapsed/refractory multiple myeloma patients exhibiting only biochemical progression-A single center retrospective study.

Regidor BS, Jew S, Goldwater MS, Beatty BM, Bujarski S, ElSayed A, Danis R, Kim S, Swift R, Schwartz G, Berenson JR. Regidor BS, et al. Among authors: bujarski s. Eur J Haematol. 2023 Oct;111(4):628-635. doi: 10.1111/ejh.14057. Epub 2023 Jul 24. Eur J Haematol. 2023. PMID: 37485542

9

High risk lung nodule: A multidisciplinary approach to diagnosis and management.

Mankidy BJ, Mohammad G, Trinh K, Ayyappan AP, Huang Q, Bujarski S, Jafferji MS, Ghanta R, Hanania AN, Lazarus DR. Mankidy BJ, et al. Among authors: bujarski s. Respir Med. 2023 Aug;214:107277. doi: 10.1016/j.rmed.2023.107277. Epub 2023 May 13. Respir Med. 2023. PMID: 37187432 Review.

10

Loss of anti-spike antibodies following mRNA vaccination for COVID-19 among patients with multiple myeloma.

Stampfer SD, Bujarski S, Goldwater MS, Jew S, Regidor B, Chen H, Xu N, Li M, Fung E, Swift R, Beatty B, Eshaghian S, Berenson JR. Stampfer SD, et al. Among authors: bujarski s. Cancer Rep (Hoboken). 2023 May;6(5):e1803. doi: 10.1002/cnr2.1803. Epub 2023 Mar 9. Cancer Rep (Hoboken). 2023. PMID: 36891732 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters